Trial intelligence / Profile preview

Ketamine and Dexmedetomidine in Cardiac Surgery

NCT05474183Completed

Sponsor
Fayoum University Hospital
Start
Aug 2022
Primary completion
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ketamine and dexmedetomidine in postoperative pain (3 arms), sponsored by Fayoum University Hospital. Primary endpoint: Total postoperative fentanyl consumption at 48 hours. Started Aug 2022; status: completed.

02

Drugs

ketaminedexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05474183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05474183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call